Try our mobile app

( ! ) Notice: Undefined index: content_SEDAR in /home/www/eninvs.com/html/blocks/block_press_release.php on line 97
Call Stack
#TimeMemoryFunctionLocation
10.0002235312{main}( ).../press_release.php:0
20.61086903688include_once( '/home/www/eninvs.com/html/blocks/block_press_release.php' ).../press_release.php:5

( ! ) Notice: Undefined index: moment in /home/www/eninvs.com/html/blocks/block_press_release.php on line 181
Call Stack
#TimeMemoryFunctionLocation
10.0002235312{main}( ).../press_release.php:0
20.61086903688include_once( '/home/www/eninvs.com/html/blocks/block_press_release.php' ).../press_release.php:5

( ! ) Notice: Undefined index: insert_status in /home/www/eninvs.com/html/blocks/block_press_release.php on line 192
Call Stack
#TimeMemoryFunctionLocation
10.0002235312{main}( ).../press_release.php:0
20.61086903688include_once( '/home/www/eninvs.com/html/blocks/block_press_release.php' ).../press_release.php:5

Charles River Laboratories to Present at Barclays Global Healthcare Conference

Published: 2021-03-08 13:30:00 ET
<<<  go to CRL company page

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will virtually present at the Barclays Global Healthcare Conference on Wednesday, March 10th, at 10:20 a.m. ET. Management will present an overview of Charles River’s strategic focus and business developments.

A live webcast of the presentation will be available through a link that will be posted on the Investor Relations section of the Charles River website at ir.criver.com. A webcast replay will be accessible through the same website after the presentation and will remain available for approximately two weeks.

About Charles River

Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.

Investor Relations Contact: Todd Spencer Corporate Vice President, Investor Relations 781.222.6455 todd.spencer@crl.com

Source: Charles River Laboratories International, Inc.